Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2000-05-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.283.18.2395PMID 10815082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

  2018cited by this paper
• State University of New York at Stony Brook Health Sciences Center.

  2000cited by this paper
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

  1999cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

  1999cited by this paper
• Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

  1999cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Controlling Acute Elevation of Plasma Fibrinogen with Ancrod

  1998cited by this paper
• Alteplase not yet proven for acute ischaemic stroke.

  1998cited by this paper
• A Methodology for the Health Sciences

  1997cited by this paper
• Risk factors, outcomes, and stroke subtypes for ischemic stroke

  1997cited by this paper
• Thrombolytic therapy with streptokinase in acute ischemic stroke.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

  1995cited by this paper
• Ancrod as prophylaxis or treatment for thromboembolism in patients with multiple trauma.

  1995cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

  1995cited by this paper
• RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

  1995cited by this paper
• Ancrod for the Treatment of Acute Ischemic Brain Infarction

  1994cited by this paper
• Biostatistics: A Methodology for the Health Sciences

  1993cited by this paper
• Reliability of Scandinavian Neurological Stroke Scale

  1991cited by this paper
• Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

  1991cited by this paper
• Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.

  1990cited by this paper
• Ancrod causes rapid thrombolysis in patients with acute stroke.

  1990cited by this paper
• Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.

  1989cited by this paper
• Use of ancrod in acute or progressing ischemic cerebral infarction.

  1988cited by this paper
• Multicenter Trial of Hemodilution in Ischemic Stroke — Background and Study Protocol

  1985cited by this paper
• Controlled trial of ancrod in ischemic stroke.

  1983cited by this paper
• Central retinal vein thrombosis: serial treatment with defibrination, aspirin and plasminotropic drugs.

  1979cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper
• Subcutaneous Ancrod after Operation for Fractured Hip - a Dose-Ranging and Feasibility Study

  1978cited by this paper
• Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study.

  1978cited by this paper
• Controlled Defibrination in the Treatment of Peripheral Vascular Disease

  1978cited by this paper
• Low-dosage Ancrod for Prevention of Thrombotic Complications after Surgery for Fractured Neck of Femur

  1974cited by this paper
• Influence of Arwin on the flow properties of blood

  1973cited by this paper
• Controlled trial of ancrod and heparin in treatment of deep-vein thrombosis of lower limb.

  1972cited by this paper
• Anticoagulant therapy with a purified fraction of Malayan pit viper venom.

  1968cited by this paper
• Therapeutic defibrination in the treatment of thrombotic disease.

  1968cited by this paper
• A Study of the Coagulant Properties of Malayan Pit‐Viper Venom

  1965cited by this paper
• Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite.

  1963cited by this paper

• Novel thrombolytic agents for acute ischemic stroke: A comprehensive review of current evidence.

  2025cites this paper
• Animal Venom in Modern Medicine: A Review of Therapeutic Applications

  2025cites this paper
• Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study.

  2025cites this paper
• Fibrinogen and Neuroinflammation in the Neurovascular Unit in Stroke

  2025influential citation
• Efficacy and safety of batroxobin in patients with acute ischemic stroke: A multicenter retrospective analysis

  2024cites this paper
• Regulation of fibrinogen synthesis.

  2024cites this paper
• Beta spending function based on conditional power in group sequential design

  2024cites this paper
• Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones

  2024cites this paper
• Therapeutic potential of snake venom: Toxin distribution and opportunities in deep learning for novel drug discovery

  2024cites this paper
• Hematology products from snake venoms.

  2024cites this paper
• De Novo Venom Gland Transcriptome Assembly and Characterization for Calloselasma rhodostoma (Kuhl, 1824), the Malayan Pit Viper from Malaysia: Unravelling Toxin Gene Diversity in a Medically Important Basal Crotaline

  2023cites this paper
• Microcirculation No-Reflow Phenomenon after Acute Ischemic Stroke

  2023cites this paper
• Global trends and research hotspots of stroke and magnetic resonance imaging: A bibliometric analysis

  2023cites this paper
• Utilisation of compounds from venoms in drug discovery.

  2021cites this paper
• Anticuagulants: An overview of Natural and Synthetic Therapeutic Anticoagulants

  2021cites this paper
• Revisiting promising preclinical intracerebral hemorrhage studies to highlight repurposable drugs for translation

  2020cites this paper
• Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience

  2020cites this paper
• Anticancer potential of nanogold conjugated toxin GNP-NN-32 from Naja naja venom

  2020cites this paper
• Acute Ischaemic Stroke

  2019cites this paper
• Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

  2019cites this paper
• Exogenous Factors from Venomous and Hematophagous Animals in Drugs and Diagnostic Developments for Cardiovascular and Neurovascular Diseases.

  2019cites this paper
• Omics Technologies for Profiling Toxin Diversity and Evolution in Snake Venom: Impacts on the Discovery of Therapeutic and Diagnostic Agents.

  2019cites this paper
• Specific treatment of acute ischemic stroke

  2019cites this paper
• Proteomic investigation of the molecular mechanism of king cobra venom L-amino acid oxidase induced apoptosis of human breast cancer (MCF-7) cell line

  2018cites this paper
• Defibrinogen Therapy for Acute Ischemic Stroke: 1332 Consecutive Cases

  2018cites this paper
• Toxins Are an Excellent Source of Therapeutic Agents against Cardiovascular Diseases

  2018cites this paper
• An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH

  2018cites this paper
• Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke

  2018cites this paper
• Reflections on Neuroprotection Research and the Path Toward Clinical Success

  2017cites this paper
• Intravenous Thrombolytic Therapy

  2017cites this paper
• Do We Have a Chance to Translate Bench-top Results to the Clinic Adequately? An Opinion

  2017cites this paper
• Outcomes after acute intracerebral haemorrhage

  2017cites this paper
• Efficacious Naturally Occurring Anti-cerebral Ischaemia Extracts, Compounds and Formulations Data from Animal Models

  2017cites this paper
• Acute Thrombolysis in Ischemic Cerebrovascular Disease

  2016cites this paper
• Changing Management of Acute Ischaemic Stroke: the New Treatments and Emerging Role of Endovascular Therapy

  2016cites this paper
• Thrombolytic protein from cobra venom with anti-adhesive properties.

  2016cites this paper
• Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi

  2016cites this paper
• Konig , Inke and Ziegler , Andreas and Bluhmki , Enrich and Hacke , Werner and Bath ,

  2016cites this paper
• Expanding the concept of neuroprotection for acute ischemic stroke: The pivotal roles of reperfusion and the collateral circulation.

  2016cites this paper
• Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis

  2016cites this paper
• 51 – Intravenous Thrombolysis

  2016cites this paper
• Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

  2016cites this paper
• [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].

  2015cites this paper
• Reperfusion Strategies for Acute Ischaemic Stroke From Past to Present: An Overview Towards Future Perspectives

  2015cites this paper
• Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke

  2015cites this paper
• Guidelines for the treatment of acute ischaemic stroke

  2014cites this paper
• Guidelines for the treatment of acute ischaemic stroke.

  2014cites this paper
• Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.

  2014cites this paper
• Exogenous Procoagulant Factors as Therapeutic and Biotechnological Tools

  2014cites this paper
• Reperfusion Therapies of Acute Ischemic Stroke: Potentials and Failures

  2014cites this paper
• Multimodal CT imaging in acute ischemic stroke

  2014cites this paper
• Nano gold conjugation, anti-arthritic potential and toxicity studies of snake Naja kaouthia (Lesson, 1831) venom protein toxin NKCT1 in male albino rats and mice.

  2014cites this paper
• Advances in Medical Revascularisation Treatments in Acute Ischemic Stroke

  2014cites this paper
• The Quest for Arterial Recanalization in Acute Ischemic Stroke-The Past, Present and the Future

  2013cites this paper
• Guideline for Healthcare Professionals From the American Heart Association/American Guidelines for the Early Management of Patients With Acute Ischemic Stroke : A

  2013cites this paper
• tPA as a therapeutic target in stroke

  2013cites this paper
• Plasminogen Activators and Ischemic Stroke: Conditions for Acute Delivery

  2013cites this paper
• Management of Acute Ischemic Stroke

  2013cites this paper
• Drug Treatment of Acute Ischemic Stroke

  2013cites this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cites this paper
• Coagulant thrombin-like enzyme (barnettobin) from Bothrops barnetti venom: molecular sequence analysis of its cDNA and biochemical properties.

  2013cites this paper
• Oral fibrinogen‐depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel‐group and controlled clinical trial

  2013cites this paper
• Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future.

  2013cites this paper
• New guidelines on tPA in stroke: putting out fires with gasoline?

  2013cites this paper
• Adjunctive and Alternative Approaches to Current Reperfusion Therapy

  2012cites this paper
• Biochemistry of envenomation.

  2012cites this paper
• Advances in thrombolytics for treatment of acute ischemic stroke

  2012cites this paper
• From snake venom toxins to therapeutics--cardiovascular examples.

  2012cites this paper
• Lumbrokinase in reversing carotid atherosclerotic plaques of patients with ischemic cerebrovascular disease

  2012cites this paper
• Fibrinogen depleting agents for acute ischaemic stroke.

  2012cites this paper
• Drug Therapy of Cerebrovascular Disease

  2011cites this paper
• 49 – Intravenous Thrombolysis

  2011cites this paper
• Acute Medical Management of Ischemic/Hemorrhagic Stroke

  2011cites this paper
• Thermal detoxification of the venom from Daboia russelli russelli of Eastern India with restoration of fibrinolytic activity.

  2011cites this paper
• Intravenous (IV) Thrombolysis

  2011influential citation
• Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal

  2011cites this paper
• Linking inflammation and coagulation: novel drug targets to treat organ ischemia

  2011cites this paper
• Ancrod and Fibrin Formation: Perspectives on Mechanisms of Action

  2011cites this paper
• The Mechanisms of Neuroprotection by Melatonin in Cerebral Ischaemia Reperfusion

  2011cites this paper
• Incidence of subclinical coronary atherosclerosis in patients with suspected embolic stroke using cardiac computed tomography

  2011cites this paper
• II. Cerebral infarction/transient ischemic attack (TIA).

  2011cites this paper
• Therapeutic Strategies in CEREBRAL ISCHEMIA Therapeutic Strategies in CEREBRAL

  2011cites this paper
• Importance of fibrinogen and the rheological properties of blood in atherosclerosis and coronary artery disease

  2010cites this paper
• Modeling stroke management: a qualitative review of cost-effectiveness analyses

  2010cites this paper
• The Virtual International Stroke Trials Archive (VISTA): Results and Impact on Future Stroke Trials and Management of Stroke Patients

  2010cites this paper
• Fibrinogen and the Risk of Thrombosis

  2010cites this paper
• The Relationship between Insulin Resistance and Hypercoagulability in Acute Ischemic Stroke

  2010cites this paper
• Hyperacute Therapies for Childhood Stroke: A Case Report and Review of the Literature

  2010cites this paper
• Randomized clinical stroke trials in 2004.

  2010cites this paper
• Thrombolysis for Acute Ischemic Stroke

  2009cites this paper
• Ancrod in Acute Ischemic Stroke: Results of 500 Subjects Beginning Treatment Within 6 Hours of Stroke Onset in the Ancrod Stroke Program

  2009cites this paper
• Old and New Anticoagulant Agents for the Prevention and Treatment of Patients with Ischemic Stroke

  2009cites this paper
• Emerging drugs for acute ischemic stroke.

  2009cites this paper
• Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when.

  2009cites this paper
• Intraoperative magnesium infusion during carotid endarterectomy: a double-blind placebo-controlled trial.

  2009cites this paper
• Bioethical Considerations in Translational Research: Primate Stroke

  2009cites this paper
• Emerging drugs for acute ischemic stroke

  2009cites this paper
• Review of current and emerging therapies in acute ischemic stroke

  2009cites this paper
• Uremic and Dialysis Encephalopathies

  2009cites this paper
• Recanalization Therapies in Acute Ischemic Stroke: Pharmacological Agents, Devices, and Combinations

  2009cites this paper